Asthma, allograft rejection, and graft versus host disease signatures reflect downregulation of MHC classes I and II which in turn reduces responsiveness of anti-tumor immune cells and is typical tumor evasion of the immune response [55,56] (GSEA results in the supplement). This evidence concerns the gene HLA-C and asthma.